India to France: Immunoglobulin Export Trade Route

The India to France Immunoglobulin corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $3.4M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's immunoglobulin manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $100.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #16 among India's top immunoglobulin export destinations globally.

On the import side, key buyers of Indian immunoglobulin in France include SIFA AERIEN, SIFA AERIEN ZONE DE, SIFA AERIEN and 3 others. SIFA AERIEN is the single largest importer with 21 shipments valued at $2.8M USD.

India's immunoglobulin exports to France are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , VIRCHOW HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $100.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rhoclone 300 mcg lyophilized [anti rho-d immunoglobulin injection monoclonal] and rhoclone 300 mcg lyophilized anti rho d immunoglobulin injection monoclonal, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SIFA AERIEN is the largest importer with 21 shipments worth $2.8M USD — representing 81% of all immunoglobulin imports from India on this route. A total of 6 buyers are active on this corridor.